BHBIA & MEMBER NEWS

Back to News List

BHBIA NEWS

BHBIA welcomes new Board Directors

May 13th, 2025

We are delighted to announce two new directors have joined the BHBIA Board.

Joining the agency/consultancy division is newly elected Hannah Brown, Global Head of Marketing, M3 Global Research and Mo Muhsin, Associate Director EMEA Business Intelligence, Eisai Europe Ltd has been co-opted to the industry division. They both bring a wealth of industry experience and expertise to the Association. 

Paul O'Nions, Founder of GTMx Consulting Ltd has also been elected as an agency/consultancy division member and Nick Coolican Smith, Director of CRM & CRM Business Intelligence, Theramex has been re-elected as an industry division member. 

We bid farewell and thank Kelly West, Anni Neumann and Dan Wright for their valuable contributions during their tenure. 

Hannah Brown

"I'm delighted to be joining the BHBIA's Board of Directors and am looking forward to my tenure immensely. I particularly welcome the opportunity to support the association's journey navigating a constantly evolving landscape, and keeping our members up to date, and more importantly engaged, with both evolutionary and revolutionary changes. 

In my role at M3 I am fortunate to work with both UK-based and global healthcare market research stakeholders, and I am excited about sharing those sometimes divergent perspectives along with insights from the most important people in our industry, our respondents.."

Mo Muhsin

"It’s a pleasure to be joining the board! I’m joining the board for several reasons but mainly because I feel that I have come to a point in my career where I can both add value the wider pharma BI community, and also gain knowledge and value from it. With my 20+ years of Pharma BI experience, I can help to shape the agenda of the BHBIA and I look forward to widening my horizons through collaboration with the board members. It is great to connect with the experienced board members and learn from the collective knowledge and expertise, aswell as debate areas that are evolving. I have an interest in oncology and currently trying to develop my digital, AI and Omnichannel capabilities as well as that of my organisation. It would be great to learn what best practice looks like in some of these areas, and how this may benefit the sector and ultimately patients."

The Board, comprised of 10 members from industry and agency/consultancy, sets the BHBIA's strategic direction. It is committed to bringing initiatives to life and delivering events to meet members' current and future needs. Board members are volunteers who have the support of their organisations and commit time and energy to the BHBIA. You can view the full Board here.

We hope you will join us in welcoming our new members to the BHBIA Board and wishing them every success!